Importantly, numerous studies have demonstrated elevated levels of serum FGF21 and GDF15 in patients with mitochondrial disease (MD) characterized by myopathy (45–47), but also in age-related diseases (48). Here, FGF21 is linked to inborn mitochondrial metabolism disorder.